Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
LaunchKenox Pharmaceuticals Inc announces the expansion of its drug development services with new non-sterile GMP capabilities to support GLP pre-clinical studies.
Kenox Pharmaceuticals has added small scale non-sterile GMP capabilities to enhance its drug development services. This expansion aims to accelerate the process from molecule to clinic, enabling partners to bring innovative therapies to market more efficiently.
Company Information
Company
Kenox Pharmaceuticals
Location
11 Deerpark Dr
Monmouth Junction, New Jersey, United States
About
Kenox Pharmaceuticals Inc is a fast-growing company dedicated to developing innovative Orally Inhaled and Nasal Drug Products (OINDPs). Established in 2018, Kenox specializes in pharmaceutical aerosol product development, offering expertise in formulation design, compounding, fill-finish, and testing in compliance with compendial monographs. The company aims to accelerate the journey from molecule to clinic, providing high-quality end-to-end solutions for biopharmaceutical innovators. Kenox is committed to supporting partners in developing cutting-edge therapeutics for unmet medical needs.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Kenox Pharmaceuticals ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.